Gender | ||
Male | 772 | 82.6% |
Female | 163 | 17.4% |
Primary Tumour Localisations |
|
|
Oropharynx | 340 | 36.4% |
Larynx | 140 | 15.0% |
Hypopharynx | 131 | 14.0% |
Floor of the mouth | 120 | 12.8% |
Tongue | 53 | 5.7% |
CuP | 48 | 5.1% |
Nasopharynx | 39 | 4.2% |
Paranasal sinuses | 25 | 2.7% |
Salivary glands | 19 | 2.0% |
Skin | 11 | 1.2% |
Ear canal | 5 | 0.5% |
Lip | 4 | 0.4% |
UICC Stage | ||
I | 31 | 3.3% |
II | 72 | 7.7% |
III | 129 | 13.8% |
IVA | 656 | 70.2% |
IVB | 46 | 4.9% |
IVC | 1 | 0.1% |
Primary Tumour Resection |
| |
Without resection | 373 | 39.9% |
R0 | 381 | 40.7% |
R1 | 181 | 19.4% |